Bibliographic information

GuidelineClinical management of COVID-19: living guideline, 18 August 2023
Year of Publication2023
Issuing InstitutionWHO

Recommendation

Maintained

In adults with post COVID-19 condition exertonal desaturation and cardiac impairment following COVID-19 should be ruled out and managed before consideration of physical exercise training. While orthostatc intolerance and post-exertional symptom exacerbaton (PESE) are amenable to rehabilitation, their presence will require interventions to be modifed in view of these diagnoses for rehabilitation to be safe.

Recommended in favor

Strong

Notes and Remarks

Practical Info Exertional desaturation is more likely and should be particularly considered in the post-hospital cohort (359)(360). Exertional desaturation may be suspected in the presence of dyspnoea on exertion. Exertional desaturation can be assessed with a locally available appropriate exercise test that includes measure of oxygen status (e.g. 1 minute sit to stand with pulse oximetry) (357). Drop in pulse oxygen saturation of more than 3–4% from baseline measurements (129)(131)(133) or to 94% or below, on exercise test is considered desaturation. Exercise testing for exertional desaturation should be avoided or modified (within tolerable limits for the individual) in the presence of PESE (361). Cardiac impairment may be suspected in the presence of fast or difficulty in breathing, high resting or exertional heart rate, chest pain or palpitations (362). Post-exertional symptom exacerbation can be assessed through history taking and reporting of symptom patterns (361) (see topic Post-exertional symptom exacerbation). Orthostatic intolerance can be investigated by measuring heart rate and blood pressure in lying and prolonged standing with an active stand test (357) (see topic Orthostatic intolerance). Red flags for safe rehabilitation may be unclear and depend on the clinical skills of the team and availability of diagnostic investigations. Clinical teams should have access to training to screen for and identify red flags (135). Tests and investigations of red flags should be tailored to people’s signs and symptoms to rule out and prevent life threatening complications (357). No one set of investigations and tests would be suitable for everyone because of the wide range of symptoms and severity.

Also Featured In

This recommendation also appears in the following guidelines:

Originally Developed
Guideline

Clinical management of COVID-19: living guideline, 15 September 2022.

Year2022
InstitutionWHO
Guideline

Clinical management of COVID-19: living guideline, 13 January 2023.

Year2023
InstitutionWHO